JP Morgan Chase 2025
San Francisco, CA
January 13, 2025 – January 14, 2025
Agenda
Monday, January 13, 2025
8:00 am - 10:00 am PT
The outlook for biopharmaceutical policy in 2025
The Incubate Coalition and DLA Piper will host a forum on the outlook for biopharmaceutical policy in 2025. The panelists will consider implications of the election for pricing and reimbursement, the regulators including CMS, FDA and the FTC and what might be the policy focus on PBMs and health plans. The discussion will be moderated by John Stanford, Executive Director of the Incubate Coalition with Guarav Gupta, Managing Partner of Life Science Private Capital at JP Morgan Chase & Co., Kirsten Axelsen and former Sen. Richard Burr, Senior Policy Advisors to DLA Piper.
Speakers:
- John Stanford, Executive Director, Incubate
- Richard Burr, Chair, Health Policy Strategic Consulting practice, DLA Piper
- Kirsten Axelsen, Senior Policy Advisor, DLA Piper
- Gaurav Gupta, Managing Partner, Life Science Private Capital, JP Morgan Private Capital
- Nina Kjellson, General Partner, Canaan Partners
- Lori M. Reilly, Chief Operating Officer, PhRMA
12:00 pm - 2:00 pm PT
Life Science financings: Lessons from 2024 and what to expect in 2025
An investment landscape marked by economic, regulatory, and heightened geopolitical uncertainties resulted in a tough year in 2024. Despite these challenges, the industry remained resilient and innovative, continuing to make investments in companies that serve patients and create new opportunities. This panel will review life science financing transactions from 2024 and discuss the trends expected to shape the sector in 2025. Our panelists will offer comprehensive insights from the perspectives of traditional venture capital, corporate venture capital, and venture debt, complemented by an overview from an experienced investment banker.
Speakers:
- Shehzad Huda, Partner, DLA Piper
- Paimun (PJ) Amini, Sr. Director, Venture Investments, Leaps by Bayer
- Robert Dentice, Managing Director, Co-Head of Healthcare Investment Banking, BTIG
- Patrick Heron, Managing Partner, Frazier Life Sciences
- Jonathan Norris, Managing Director, HSBC Innovation Banking
9:00 pm - 12:00 am PT
DLA Piper Finance team late night at JP Morgan
Please join the DLA Piper Finance team for our annual after-hours party featuring handcrafted cocktails, late night snacks and networking with the leading healthcare and life sciences lenders, investors and companies.
Tuesday, January 14, 2025
12:00 pm - 2:00 pm PT
Beyond the ballot: Navigating healthcare/life sciences investments and policies in a new political landscape – a strategic discussion with former US Senator Richard Burr and leading healthcare policy legal authorities
Explore the critical intersection of politics, policy, and healthcare/life sciences investments as a new administration takes shape and state legislatures begin their sessions. This high-level dialogue will provide investors and industry leaders with actionable insights on:
Federal Policy Shifts: Analysis of emerging healthcare priorities under the new administration and Congress
State-Level Changes: Understanding the implications of newly elected state officials on healthcare regulation and consolidation
Investment Strategy: Identifying opportunities and risks in the evolving regulatory environment
Antitrust Landscape: Navigate the changing approach to healthcare mergers and acquisitions
Innovation Impact: How policy shifts may affect investment in healthcare technology and Life Sciences
Drawing on Senator Burr's extensive healthcare policy experience and relationships with key decisionmakers, alongside insights from leading healthcare legal authorities, this session will provide a comprehensive roadmap for healthcare investors and operators in the post-election environment.
Speakers:
- Joshua Kaye, Chair, US Healthcare sector, Partner, DLA Piper
- Richard Burr, Chair, Health Policy Strategic Consulting practice, DLA Piper
- Darren Patz, Partner, DLA Piper
5:00 pm - 8:00 pm PT
DLA Piper reception
We hope you will join us to reconnect over cocktails and hors d’oeuvres as we gather with industry professionals and invite you to get to know our partners and colleagues.